Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2009
DOI: 10.1093/nar/gkp526
|View full text |Cite
|
Sign up to set email alerts
|

Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays

Abstract: Clinical DNA is often available in limited quantities requiring whole-genome amplification for subsequent genome-wide assessment of copy-number variation (CNV) by array-CGH. In pre-implantation diagnosis and analysis of micrometastases, even merely single cells are available for analysis. However, procedures allowing high-resolution analyses of CNVs from single cells well below resolution limits of conventional cytogenetics are lacking. Here, we applied amplification products of single cells and of cell pools … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
62
0

Year Published

2010
2010
2015
2015

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 65 publications
(63 citation statements)
references
References 20 publications
1
62
0
Order By: Relevance
“…10 As shown previously, no major artifacts were induced by whole-genome amplification and a similar signal-to-noise ratio of the aCGH profile was observed when using amplified or non-amplified DNA. 11 aCGH was performed in all cases in which DNA was available. Briefly, 250 ng unamplified or amplified DNA was labeled using the Bioprime Array CGH Genomic Labeling Kit according to the manufacturer's instructions (Invitrogen, Carlsberg, CA, USA).…”
Section: Dna Extraction and Acghmentioning
confidence: 99%
“…10 As shown previously, no major artifacts were induced by whole-genome amplification and a similar signal-to-noise ratio of the aCGH profile was observed when using amplified or non-amplified DNA. 11 aCGH was performed in all cases in which DNA was available. Briefly, 250 ng unamplified or amplified DNA was labeled using the Bioprime Array CGH Genomic Labeling Kit according to the manufacturer's instructions (Invitrogen, Carlsberg, CA, USA).…”
Section: Dna Extraction and Acghmentioning
confidence: 99%
“…Intratumor heterogeneity studies profiling or sequencing DNA from individual tumor cells require whole-genome amplification (WGA). By using commercially available methods for WGA, it is possible to amplify DNA from a single cell to a level where it can be profiled by microarrays, but these studies have been challenged by technical difficulty and limited reproducibility (75)(76)(77)(78). Analyzing WGA fragments from single cells using targeted approaches such as DNA microarrays is problematic because fragments are randomly amplified from a small fraction (<10%) of the genome, and thus many fail to hybridize to their target probes.…”
Section: Figurementioning
confidence: 99%
“…15 To obtain a high purity of tumor DNA, only areas with a tumor cell infiltration of over 90% were microdissected for DNA isolation using the QIAamp DNA formalin-fixed, paraffinembedded tissue kit (Qiagen, Hilden, Germany). Samples were labeled with a bioprime array CGH genomic labeling kit according to the manufacturer's instructions (Invitrogen, Carlsberg, CA, USA).…”
Section: Array Cghmentioning
confidence: 99%